{"parse":{"title":"History of hypertension","pageid":35958818,"revid":854609072,"text":{"*":"<div class=\"mw-parser-output\"><p>The modern <b>history of hypertension</b> begins with the understanding of the cardiovascular system based on the work of physician <a href=\"/wiki/William_Harvey\" title=\"William Harvey\">William Harvey</a> (1578\u20131657), who  described the circulation of blood in his book \"<i>De motu cordis</i>\". The English clergyman <a href=\"/wiki/Stephen_Hales\" title=\"Stephen Hales\">Stephen Hales</a> made the first published measurement of blood pressure in 1733.<sup id=\"cite_ref-Esunge1991rev_1-0\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Kotchen2011_2-0\" class=\"reference\"><a href=\"#cite_note-Kotchen2011-2\">&#91;2&#93;</a></sup> Descriptions of what would come to be called hypertension came from among others, <a href=\"/wiki/Thomas_Young_(scientist)\" title=\"Thomas Young (scientist)\">Thomas Young</a> in 1808 and especially <a href=\"/wiki/Richard_Bright_(physician)\" title=\"Richard Bright (physician)\">Richard Bright</a> in 1836.<sup id=\"cite_ref-Esunge1991rev_1-1\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup> Bright noted a link between cardiac hypertrophy and kidney disease, and subsequently kidney disease was often termed <a href=\"/wiki/Bright%27s_disease\" title=\"Bright&#39;s disease\">Bright's disease</a> in this period. In 1850 George Johnson suggested that the thickened blood vessels seen in the kidney in Bright's disease might be an adaptation to elevated blood pressure.<sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup>  William Senhouse Kirkes in 1855 and Ludwig Traube in 1856 also proposed, based on pathological observations, that elevated pressure could account for the association between left ventricular hypertrophy to kidney damage in Bright's disease.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup>  Samuel Wilks observed that left ventricular hypertrophy and diseased arteries were not necessarily associated with diseased kidneys,<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup> implying that high blood pressure might occur in people with healthy kidneys; however the first report of elevated blood pressure in a person without evidence of kidney disease was made by <a href=\"/wiki/Frederick_Akbar_Mahomed\" title=\"Frederick Akbar Mahomed\">Frederick Akbar Mahomed</a> in 1874 using a <a href=\"/wiki/Sphygmograph\" title=\"Sphygmograph\">sphygmograph</a>.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup> The concept of hypertensive disease as a generalized circulatory disease was taken up by <a href=\"/wiki/Clifford_Allbutt\" title=\"Clifford Allbutt\">Sir Clifford Allbutt</a>, who termed the condition \"hyperpiesia\".<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>  However hypertension as a medical entity really came into being in 1896 with the invention of the cuff-based <a href=\"/wiki/Sphygmomanometer\" title=\"Sphygmomanometer\">sphygmomanometer</a> by <a href=\"/wiki/Scipione_Riva-Rocci\" title=\"Scipione Riva-Rocci\">Scipione Riva-Rocci</a> in 1896,<sup id=\"cite_ref-9\" class=\"reference\"><a href=\"#cite_note-9\">&#91;9&#93;</a></sup> which allowed <a href=\"/wiki/Blood_pressure\" title=\"Blood pressure\">blood pressure</a> to be measured in the clinic. In 1905, <a href=\"/wiki/Nikolai_Korotkoff\" class=\"mw-redirect\" title=\"Nikolai Korotkoff\">Nikolai Korotkoff</a> improved the technique by describing the <a href=\"/wiki/Korotkoff_sounds\" title=\"Korotkoff sounds\">Korotkoff sounds</a> that are heard when the artery is ausculated with a stethoscope while the sphygmomanometer cuff is deflated.<sup id=\"cite_ref-Kotchen2011_2-1\" class=\"reference\"><a href=\"#cite_note-Kotchen2011-2\">&#91;2&#93;</a></sup>\n</p><p>The term <a href=\"/wiki/Essential_hypertension\" title=\"Essential hypertension\">essential hypertension</a> ('Essentielle Hypertonie') was coined by Eberhard Frank in 1911 to describe elevated blood pressure for which no cause could be found.<sup id=\"cite_ref-Korner2007_10-0\" class=\"reference\"><a href=\"#cite_note-Korner2007-10\">&#91;10&#93;</a></sup> In 1928, the term <a href=\"/wiki/Malignant_hypertension\" class=\"mw-redirect\" title=\"Malignant hypertension\">malignant hypertension</a> was coined by physicians from the <a href=\"/wiki/Mayo_Clinic\" title=\"Mayo Clinic\">Mayo Clinic</a> to describe a syndrome of very high blood pressure, severe retinopathy and inadequate kidney function which usually resulted in death within a year from <a href=\"/wiki/Stroke\" title=\"Stroke\">strokes</a>, <a href=\"/wiki/Heart_failure\" title=\"Heart failure\">heart failure</a> or <a href=\"/wiki/Kidney_failure\" title=\"Kidney failure\">kidney failure</a>.<sup id=\"cite_ref-11\" class=\"reference\"><a href=\"#cite_note-11\">&#91;11&#93;</a></sup> A prominent individual with severe hypertension was <a href=\"/wiki/Franklin_D._Roosevelt\" title=\"Franklin D. Roosevelt\">Franklin D. Roosevelt</a>.<sup id=\"cite_ref-12\" class=\"reference\"><a href=\"#cite_note-12\">&#91;12&#93;</a></sup> However, while the menace of severe or malignant hypertension was well recognised, the risks of more moderate elevations of blood pressure were uncertain and the benefits of treatment doubtful. Consequently, hypertension was often classified into \"malignant\" and \"benign\". In 1931, John Hay, Professor of Medicine at <a href=\"/wiki/Liverpool_University\" class=\"mw-redirect\" title=\"Liverpool University\">Liverpool University</a>, wrote that \"there is some truth in the saying that the greatest danger to a man with a high blood pressure lies in its discovery, because then some fool is certain to try and reduce it\".<sup id=\"cite_ref-13\" class=\"reference\"><a href=\"#cite_note-13\">&#91;13&#93;</a></sup><sup id=\"cite_ref-Moser_14-0\" class=\"reference\"><a href=\"#cite_note-Moser-14\">&#91;14&#93;</a></sup> This view was echoed by the eminent US cardiologist <a href=\"/wiki/Paul_Dudley_White\" title=\"Paul Dudley White\">Paul Dudley White</a> in 1937, who suggested that \"hypertension may be an important compensatory mechanism which should not be tampered with, even if we were certain that we could control it\".<sup id=\"cite_ref-15\" class=\"reference\"><a href=\"#cite_note-15\">&#91;15&#93;</a></sup> Charles Friedberg's 1949 classic textbook \"Diseases of the Heart\",<sup id=\"cite_ref-16\" class=\"reference\"><a href=\"#cite_note-16\">&#91;16&#93;</a></sup> stated that \"people with 'mild benign' hypertension&#160;... [defined as blood pressures up to levels of 210/100 mm Hg]&#160;... need not be treated\".<sup id=\"cite_ref-Moser_14-1\" class=\"reference\"><a href=\"#cite_note-Moser-14\">&#91;14&#93;</a></sup> However the tide of medical opinion was turning: it was increasingly recognised in the 1950s that \"benign\" hypertension was not harmless.<sup id=\"cite_ref-17\" class=\"reference\"><a href=\"#cite_note-17\">&#91;17&#93;</a></sup> Over the next decade increasing evidence accumulated from actuarial reports<sup id=\"cite_ref-Kotchen2011_2-2\" class=\"reference\"><a href=\"#cite_note-Kotchen2011-2\">&#91;2&#93;</a></sup><sup id=\"cite_ref-18\" class=\"reference\"><a href=\"#cite_note-18\">&#91;18&#93;</a></sup> and longitudinal studies, such as the <a href=\"/wiki/Framingham_Heart_Study\" title=\"Framingham Heart Study\">Framingham Heart Study</a>,<sup id=\"cite_ref-19\" class=\"reference\"><a href=\"#cite_note-19\">&#91;19&#93;</a></sup> that \"benign\" hypertension increased death and cardiovascular disease, and that these risks increased in a graded manner with increasing blood pressure across the whole spectrum of population blood pressures. Subsequently, the <a href=\"/wiki/National_Institutes_of_Health\" title=\"National Institutes of Health\">National Institutes of Health</a> also sponsored other population studies, which additionally showed that African Americans had a higher burden of hypertension and its complications.<sup id=\"cite_ref-Dustan_20-0\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Treatment_and_Medications\">Treatment and Medications</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=History_of_hypertension&amp;action=edit&amp;section=1\" title=\"Edit section: Treatment and Medications\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Historically  the treatment for what was called the \"hard pulse disease\" consisted in reducing the quantity of blood by <a href=\"/wiki/Blood_letting\" class=\"mw-redirect\" title=\"Blood letting\">blood letting</a> or the application of <a href=\"/wiki/Leech\" title=\"Leech\">leeches</a>.<sup id=\"cite_ref-Esunge1991rev_1-2\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup> This was advocated by The <a href=\"/wiki/Yellow_Emperor\" title=\"Yellow Emperor\">Yellow Emperor</a> of China, <a href=\"/wiki/Aulus_Cornelius_Celsus\" title=\"Aulus Cornelius Celsus\">Cornelius Celsus</a>, <a href=\"/wiki/Galen\" title=\"Galen\">Galen</a>, and <a href=\"/wiki/Hippocrates\" title=\"Hippocrates\">Hippocrates</a>.<sup id=\"cite_ref-Esunge1991rev_1-3\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup>\n</p><p>In the late 19th and early to mid 20th centuries, many therapies were used to treat hypertension,<sup id=\"cite_ref-21\" class=\"reference\"><a href=\"#cite_note-21\">&#91;21&#93;</a></sup><sup id=\"cite_ref-Evans_199\u2013228_22-0\" class=\"reference\"><a href=\"#cite_note-Evans_199\u2013228-22\">&#91;22&#93;</a></sup> but few were effective<sup id=\"cite_ref-:1_23-0\" class=\"reference\"><a href=\"#cite_note-:1-23\">&#91;23&#93;</a></sup><sup id=\"cite_ref-Evans_199\u2013228_22-1\" class=\"reference\"><a href=\"#cite_note-Evans_199\u2013228-22\">&#91;22&#93;</a></sup> and these were poorly tolerated.<sup id=\"cite_ref-24\" class=\"reference\"><a href=\"#cite_note-24\">&#91;24&#93;</a></sup><sup id=\"cite_ref-:0_25-0\" class=\"reference\"><a href=\"#cite_note-:0-25\">&#91;25&#93;</a></sup> Therapies used in that period included strict sodium restriction (for example the <a href=\"/wiki/Rice_diet\" title=\"Rice diet\">rice diet</a><sup id=\"cite_ref-Esunge1991rev_1-4\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup>),<sup id=\"cite_ref-:2_26-0\" class=\"reference\"><a href=\"#cite_note-:2-26\">&#91;26&#93;</a></sup> <a href=\"/wiki/Sympathectomy\" title=\"Sympathectomy\">sympathectomy</a> (surgical ablation of parts of the <a href=\"/wiki/Sympathetic_nervous_system\" title=\"Sympathetic nervous system\">sympathetic nervous system</a>),<sup id=\"cite_ref-:2_26-1\" class=\"reference\"><a href=\"#cite_note-:2-26\">&#91;26&#93;</a></sup> and pyrogen therapy (injection of substances that caused a fever, indirectly reducing blood pressure).<sup id=\"cite_ref-Esunge1991rev_1-5\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Dustan_20-1\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup> The first chemical for hypertension, <a href=\"/wiki/Sodium_thiocyanate\" title=\"Sodium thiocyanate\">sodium thiocyanate</a>, was used in 1900 but had many side effects<sup id=\"cite_ref-:1_23-1\" class=\"reference\"><a href=\"#cite_note-:1-23\">&#91;23&#93;</a></sup> and was unpopular.<sup id=\"cite_ref-Esunge1991rev_1-6\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup> Other treatments, such as <a href=\"/wiki/Barbiturate\" title=\"Barbiturate\">barbiturates</a>, <a href=\"/wiki/Bismuth\" title=\"Bismuth\">bismuth</a>,  and  <a href=\"/wiki/Bromide\" title=\"Bromide\">bromides</a>  were  mainly  supportive rather than therapeutic.<sup id=\"cite_ref-:0_25-1\" class=\"reference\"><a href=\"#cite_note-:0-25\">&#91;25&#93;</a></sup> Other drugs were used after the <a href=\"/wiki/World_War_II\" title=\"World War II\">Second World War</a>, the most popular and reasonably effective of which were <a href=\"/wiki/Tetramethylammonium_chloride\" title=\"Tetramethylammonium chloride\">tetramethylammonium chloride</a> and its derivative <a href=\"/wiki/Hexamethonium\" title=\"Hexamethonium\">hexamethonium</a>.<sup id=\"cite_ref-27\" class=\"reference\"><a href=\"#cite_note-27\">&#91;27&#93;</a></sup> Also used in the post-war period were <a href=\"/wiki/Hydralazine\" title=\"Hydralazine\">hydralazine</a><sup id=\"cite_ref-28\" class=\"reference\"><a href=\"#cite_note-28\">&#91;28&#93;</a></sup> and <a href=\"/wiki/Reserpine\" title=\"Reserpine\">reserpine</a> (derived from the medicinal plant <i><a href=\"/wiki/Rauwolfia_serpentina\" class=\"mw-redirect\" title=\"Rauwolfia serpentina\">Rauwolfia serpentina</a></i>).<sup id=\"cite_ref-29\" class=\"reference\"><a href=\"#cite_note-29\">&#91;29&#93;</a></sup>\n</p><p>A major breakthrough was achieved in the 1950s with the discovery of well-tolerated oral <a href=\"/wiki/Diuretics\" class=\"mw-redirect\" title=\"Diuretics\">diuretics</a>, the first of which was <a href=\"/wiki/Chlorothiazide\" title=\"Chlorothiazide\">chlorothiazide</a> (Diuril).<sup id=\"cite_ref-30\" class=\"reference\"><a href=\"#cite_note-30\">&#91;30&#93;</a></sup> This was derived from the antibiotic <a href=\"/wiki/Sulfanilamide\" title=\"Sulfanilamide\">sulfanilamide</a> and became available in 1958.<sup id=\"cite_ref-Esunge1991rev_1-7\" class=\"reference\"><a href=\"#cite_note-Esunge1991rev-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-31\" class=\"reference\"><a href=\"#cite_note-31\">&#91;31&#93;</a></sup> A <a href=\"/wiki/Randomized_controlled_trial\" title=\"Randomized controlled trial\">randomized controlled trial</a>  sponsored by the <a href=\"/wiki/United_States_Department_of_Veterans_Affairs\" title=\"United States Department of Veterans Affairs\">Veterans Administration</a> comparing <a href=\"/wiki/Hydrochlorothiazide\" title=\"Hydrochlorothiazide\">hydrochlorothiazide</a> plus reserpine plus hydralazine versus placebo had to be stopped early because those not receiving treatment developed many more complications and it was deemed unethical to withhold treatment from them. The study continued in people with lower blood pressures and showed that treatment even in people with mild hypertension more than halved the risk of cardiovascular death.<sup id=\"cite_ref-Moser_14-2\" class=\"reference\"><a href=\"#cite_note-Moser-14\">&#91;14&#93;</a></sup><sup id=\"cite_ref-32\" class=\"reference\"><a href=\"#cite_note-32\">&#91;32&#93;</a></sup> In 1975, the <a href=\"/wiki/Lasker_Award\" title=\"Lasker Award\">Lasker Special Public Health Award</a> was awarded to the team that developed chlorothiazide.<sup id=\"cite_ref-Dustan_20-2\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup> The results of these studies prompted public health campaigns to increase public awareness of hypertension and promoted the measurement and treatment of high blood pressure. These measures appear to have contributed at least in part to the observed 50% fall in stroke and ischemic heart disease between 1972 and 1994.<sup id=\"cite_ref-Dustan_20-3\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup>\n</p><p>Soon more drugs became available to treat hypertension. The British physician <a href=\"/wiki/James_W._Black\" class=\"mw-redirect\" title=\"James W. Black\">James W. Black</a> developed <a href=\"/wiki/Beta_blocker\" title=\"Beta blocker\">beta blockers</a> in the early 1960s;<sup id=\"cite_ref-33\" class=\"reference\"><a href=\"#cite_note-33\">&#91;33&#93;</a></sup> these were initially used for <a href=\"/wiki/Angina_pectoris\" class=\"mw-redirect\" title=\"Angina pectoris\">angina</a>, but turned out to lower blood pressure. Black received the 1976 <a href=\"/wiki/Lasker-DeBakey_Clinical_Medical_Research_Award\" title=\"Lasker-DeBakey Clinical Medical Research Award\">Lasker Award</a> and in 1988 the <a href=\"/wiki/Nobel_Prize_in_Physiology_or_Medicine\" title=\"Nobel Prize in Physiology or Medicine\">Nobel Prize in Physiology or Medicine</a> for his discovery.<sup id=\"cite_ref-Dustan_20-4\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup> The next class of antihypertensives to be discovered were <a href=\"/wiki/Calcium_channel_blockers\" class=\"mw-redirect\" title=\"Calcium channel blockers\">calcium channel blockers</a>. The first member was <a href=\"/wiki/Verapamil\" title=\"Verapamil\">verapamil</a>, a derivative of <a href=\"/wiki/Papaverine\" title=\"Papaverine\">papaverine</a> that was initially thought to be a beta blocker and used for angina, but then turned out to have a different mode of action and was shown to lower blood pressure.<sup id=\"cite_ref-Dustan_20-5\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup> The <a href=\"/wiki/Renin%E2%80%93angiotensin_system\" title=\"Renin\u2013angiotensin system\">renin\u2013angiotensin system</a> was known to play an important role in blood pressure regulation, and <a href=\"/wiki/Angiotensin_converting_enzyme\" class=\"mw-redirect\" title=\"Angiotensin converting enzyme\">angiotensin converting enzyme</a> (ACE) inhibitors were developed through <a href=\"/wiki/Drug_design\" title=\"Drug design\">rational drug design</a>. In 1977 <a href=\"/wiki/Captopril\" title=\"Captopril\">captopril</a>, an orally active agent, was described;<sup id=\"cite_ref-34\" class=\"reference\"><a href=\"#cite_note-34\">&#91;34&#93;</a></sup> this led to the development of a number of other ACE inhibitors.<sup id=\"cite_ref-Dustan_20-6\" class=\"reference\"><a href=\"#cite_note-Dustan-20\">&#91;20&#93;</a></sup> More recently <a href=\"/wiki/Angiotensin_receptor_blockers\" class=\"mw-redirect\" title=\"Angiotensin receptor blockers\">angiotensin receptor blockers</a> and <a href=\"/wiki/Renin_inhibitors\" class=\"mw-redirect\" title=\"Renin inhibitors\">renin inhibitors</a> have also been introduced as antihypertensive agents.<sup id=\"cite_ref-35\" class=\"reference\"><a href=\"#cite_note-35\">&#91;35&#93;</a></sup><sup id=\"cite_ref-36\" class=\"reference\"><a href=\"#cite_note-36\">&#91;36&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=History_of_hypertension&amp;action=edit&amp;section=2\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap mw-references-columns\"><ol class=\"references\">\n<li id=\"cite_note-Esunge1991rev-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Esunge1991rev_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-6\"><sup><i><b>g</b></i></sup></a> <a href=\"#cite_ref-Esunge1991rev_1-7\"><sup><i><b>h</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Esunge PM (October 1991). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1295564\">\"From blood pressure to hypertension: the history of research\"</a>. <i>Journal of the Royal Society of Medicine</i>. <b>84</b> (10): 621. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1295564\">1295564</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/1744849\">1744849</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+Royal+Society+of+Medicine&amp;rft.atitle=From+blood+pressure+to+hypertension%3A+the+history+of+research&amp;rft.volume=84&amp;rft.issue=10&amp;rft.pages=621&amp;rft.date=1991-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1295564&amp;rft_id=info%3Apmid%2F1744849&amp;rft.aulast=Esunge&amp;rft.aufirst=PM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1295564&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Kotchen2011-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Kotchen2011_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Kotchen2011_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Kotchen2011_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Kotchen TA (October 2011). \"Historical trends and milestones in hypertension research: a model of the process of translational research\". <i>Hypertension</i>. <b>58</b> (4): 522\u201338. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/HYPERTENSIONAHA.111.177766\">10.1161/HYPERTENSIONAHA.111.177766</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21859967\">21859967</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hypertension&amp;rft.atitle=Historical+trends+and+milestones+in+hypertension+research%3A+a+model+of+the+process+of+translational+research&amp;rft.volume=58&amp;rft.issue=4&amp;rft.pages=522-38&amp;rft.date=2011-10&amp;rft_id=info%3Adoi%2F10.1161%2FHYPERTENSIONAHA.111.177766&amp;rft_id=info%3Apmid%2F21859967&amp;rft.aulast=Kotchen&amp;rft.aufirst=TA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johnson G (1850). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2104234\">\"On the proximate cause of albuminous urine and dropsy, and on the pathology of the renal blood-vessels in Bright's Disease\"</a>. <i>Medico-Chirurgical Transactions</i>. <b>33</b>: 107\u201320. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2104234\">2104234</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20895925\">20895925</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medico-Chirurgical+Transactions&amp;rft.atitle=On+the+proximate+cause+of+albuminous+urine+and+dropsy%2C+and+on+the+pathology+of+the+renal+blood-vessels+in+Bright%27s+Disease&amp;rft.volume=33&amp;rft.pages=107-20&amp;rft.date=1850&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2104234&amp;rft_id=info%3Apmid%2F20895925&amp;rft.aulast=Johnson&amp;rft.aufirst=G&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2104234&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cameron JS, Hicks J (February 2000). \"High blood pressure and the kidney: the forgotten contribution of William Senhouse Kirkes\". <i>Kidney International</i>. <b>57</b> (2): 724\u201334. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1046/j.1523-1755.2000.00895.x\">10.1046/j.1523-1755.2000.00895.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/10652052\">10652052</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kidney+International&amp;rft.atitle=High+blood+pressure+and+the+kidney%3A+the+forgotten+contribution+of+William+Senhouse+Kirkes&amp;rft.volume=57&amp;rft.issue=2&amp;rft.pages=724-34&amp;rft.date=2000-02&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1523-1755.2000.00895.x&amp;rft_id=info%3Apmid%2F10652052&amp;rft.aulast=Cameron&amp;rft.aufirst=JS&amp;rft.au=Hicks%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Cameron JS, Hicks J (May 1996). \"Frederick Akbar Mahomed and his role in the description of hypertension at Guy's Hospital\". <i>Kidney International</i>. <b>49</b> (5): 1488\u2013506. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/ki.1996.209\">10.1038/ki.1996.209</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8731118\">8731118</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Kidney+International&amp;rft.atitle=Frederick+Akbar+Mahomed+and+his+role+in+the+description+of+hypertension+at+Guy%27s+Hospital&amp;rft.volume=49&amp;rft.issue=5&amp;rft.pages=1488-506&amp;rft.date=1996-05&amp;rft_id=info%3Adoi%2F10.1038%2Fki.1996.209&amp;rft_id=info%3Apmid%2F8731118&amp;rft.aulast=Cameron&amp;rft.aufirst=JS&amp;rft.au=Hicks%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Swales JD, ed. (1995). <i>Manual of hypertension</i>. Oxford: Blackwell Science. pp.&#160;xiii. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-86542-861-1\" title=\"Special:BookSources/0-86542-861-1\">0-86542-861-1</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Manual+of+hypertension&amp;rft.place=Oxford&amp;rft.pages=xiii&amp;rft.pub=Blackwell+Science&amp;rft.date=1995&amp;rft.isbn=0-86542-861-1&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Shaw HB (1922). <a rel=\"nofollow\" class=\"external text\" href=\"https://archive.org/details/hyperpiesiahyper00shaw\"><i>Hyperpiesia and hyperpiesis (hypertension)&#160;: a clinical, pathological &amp; experimental study</i></a>. University of California Libraries. London&#160;: Frowde and Hodder &amp; Stoughton.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Hyperpiesia+and+hyperpiesis+%28hypertension%29+%3A+a+clinical%2C+pathological+%26+experimental+study&amp;rft.pub=London+%3A+Frowde+and+Hodder+%26+Stoughton&amp;rft.date=1922&amp;rft.aulast=Shaw&amp;rft.aufirst=H.+Batty&amp;rft_id=https%3A%2F%2Farchive.org%2Fdetails%2Fhyperpiesiahyper00shaw&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Freis E (1995). \"Historical Development of Antihypertensive Treatment\".  In Laragh J, Brenner B. <a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/oclc/30894228\"><i>Hypertension&#160;: pathophysiology, diagnosis, and management</i></a> (2nd ed.). New York: Raven Press. p.&#160;2742. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780781701570\" title=\"Special:BookSources/9780781701570\">9780781701570</a>. <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/oclc/30894228\">30894228</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Historical+Development+of+Antihypertensive+Treatment&amp;rft.btitle=Hypertension+%3A+pathophysiology%2C+diagnosis%2C+and+management&amp;rft.place=New+York&amp;rft.pages=2742&amp;rft.edition=2nd&amp;rft.pub=Raven+Press&amp;rft.date=1995&amp;rft_id=info%3Aoclcnum%2F30894228&amp;rft.isbn=9780781701570&amp;rft.aulast=Freis&amp;rft.aufirst=Edward&amp;rft_id=https%3A%2F%2Fwww.worldcat.org%2Foclc%2F30894228&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-9\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-9\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Postel-Vinay N, ed. (1996). <i>A century of arterial hypertension 1896\u20131996</i>. Chichester: Wiley. p.&#160;213. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/0-471-96788-2\" title=\"Special:BookSources/0-471-96788-2\">0-471-96788-2</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=A+century+of+arterial+hypertension+1896%E2%80%931996&amp;rft.place=Chichester&amp;rft.pages=213&amp;rft.pub=Wiley&amp;rft.date=1996&amp;rft.isbn=0-471-96788-2&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Korner2007-10\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-Korner2007_10-0\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Paul I. Korner Professor of Medicine Monash University (Emeritus) and Director of the (11 May 2007). <a rel=\"nofollow\" class=\"external text\" href=\"https://books.google.com/books?id=Q-HIVbL4OxAC&amp;pg=PA4\"><i>Essential Hypertension and Its Causes&#160;: Neural and Non-Neural Mechanisms: Neural and Non-Neural Mechanisms</i></a>. Oxford University Press, USA. pp.&#160;4\u2013. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/978-0-19-535740-0\" title=\"Special:BookSources/978-0-19-535740-0\">978-0-19-535740-0</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Essential+Hypertension+and+Its+Causes+%3A+Neural+and+Non-Neural+Mechanisms%3A+Neural+and+Non-Neural+Mechanisms&amp;rft.pages=4-&amp;rft.pub=Oxford+University+Press%2C+USA&amp;rft.date=2007-05-11&amp;rft.isbn=978-0-19-535740-0&amp;rft.au=Paul+I.+Korner+Professor+of+Medicine+Monash+University+%28Emeritus%29+and+Director+of+the&amp;rft_id=https%3A%2F%2Fbooks.google.com%2Fbooks%3Fid%3DQ-HIVbL4OxAC%26pg%3DPA4&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-11\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-11\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Keith NM, Wagener HP, Kernohan JW (1928). \"The syndrome of malignant hypertension\". <i>Arch. Intern. Med</i>. <b>41</b> (2): 141\u2013188. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archinte.1928.00130140003001\">10.1001/archinte.1928.00130140003001</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Arch.+Intern.+Med.&amp;rft.atitle=The+syndrome+of+malignant+hypertension&amp;rft.volume=41&amp;rft.issue=2&amp;rft.pages=141-188&amp;rft.date=1928&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.1928.00130140003001&amp;rft.aulast=Keith&amp;rft.aufirst=NM&amp;rft.au=Wagener%2C+HP&amp;rft.au=Kernohan%2C+JW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-12\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-12\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Bruenn HG (April 1970). \"Clinical notes on the illness and death of President Franklin D. Roosevelt\". <i>Annals of Internal Medicine</i>. <b>72</b> (4): 579\u201391. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.7326/0003-4819-72-4-579\">10.7326/0003-4819-72-4-579</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4908628\">4908628</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Internal+Medicine&amp;rft.atitle=Clinical+notes+on+the+illness+and+death+of+President+Franklin+D.+Roosevelt&amp;rft.volume=72&amp;rft.issue=4&amp;rft.pages=579-91&amp;rft.date=1970-04&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-72-4-579&amp;rft_id=info%3Apmid%2F4908628&amp;rft.aulast=Bruenn&amp;rft.aufirst=HG&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-13\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-13\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Hay J (July 1931). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2314188\">\"A British Medical Association Lecture on THE SIGNIFICANCE OF A RAISED BLOOD PRESSURE\"</a>. <i>British Medical Journal</i>. <b>2</b> (3679): 43\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/bmj.2.3679.43\">10.1136/bmj.2.3679.43</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC2314188\">2314188</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/20776269\">20776269</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Journal&amp;rft.atitle=A+British+Medical+Association+Lecture+on+THE+SIGNIFICANCE+OF+A+RAISED+BLOOD+PRESSURE&amp;rft.volume=2&amp;rft.issue=3679&amp;rft.pages=43-7&amp;rft.date=1931-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2314188&amp;rft_id=info%3Apmid%2F20776269&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.2.3679.43&amp;rft.aulast=Hay&amp;rft.aufirst=J&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2314188&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Moser-14\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Moser_14-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Moser_14-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Moser_14-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moser M (August 2006). \"Historical perspectives on the management of hypertension\". <i>Journal of Clinical Hypertension</i>. <b>8</b> (8 Suppl 2): 15\u201320; quiz 39. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1524-6175.2006.05836.x\">10.1111/j.1524-6175.2006.05836.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16894244\">16894244</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Hypertension&amp;rft.atitle=Historical+perspectives+on+the+management+of+hypertension&amp;rft.volume=8&amp;rft.issue=8+Suppl+2&amp;rft.pages=15-20%3B+quiz+39&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1524-6175.2006.05836.x&amp;rft_id=info%3Apmid%2F16894244&amp;rft.aulast=Moser&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-15\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-15\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">White PD (1937). <i>Heart Disease</i> (2nd ed.). New York, NY: MacMillan Co. p.&#160;326.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Heart+Disease&amp;rft.place=New+York%2C+NY&amp;rft.pages=326&amp;rft.edition=2nd&amp;rft.pub=MacMillan+Co.&amp;rft.date=1937&amp;rft.au=White+PD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-16\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-16\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Friedberg CK (1949). <i>Diseases of the Heart</i>. Philadelphia, PA: WB Saunders Co.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Diseases+of+the+Heart&amp;rft.place=Philadelphia%2C+PA&amp;rft.pub=WB+Saunders+Co&amp;rft.date=1949&amp;rft.au=Friedberg+CK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-17\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-17\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pickering GW (1952). \"The natural history of hypertension\". <i>British Medical Bulletin</i>. <b>8</b> (4): 305\u20139. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/12987687\">12987687</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Bulletin&amp;rft.atitle=The+natural+history+of+hypertension&amp;rft.volume=8&amp;rft.issue=4&amp;rft.pages=305-9&amp;rft.date=1952&amp;rft_id=info%3Apmid%2F12987687&amp;rft.aulast=Pickering&amp;rft.aufirst=GW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-18\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-18\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">Society of Actuaries Committee on Mortality (1960). <i>Build and blood pressure study, 1959</i>. Chicago, IL: Society of Actuaries.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Build+and+blood+pressure+study%2C+1959&amp;rft.place=Chicago%2C+IL&amp;rft.pub=Society+of+Actuaries&amp;rft.date=1960&amp;rft.au=Society+of+Actuaries+Committee+on+Mortality&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-19\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-19\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation book\">\"Section 30: Some characteristics related to the incidence of cardiovascular disease and death: 18 year follow-up\". <i>The Framingham Study; DHEW Publication No. (NIH) 74-599</i>. Bethesda, MD: National Heart and Lung Institute. 1974.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=bookitem&amp;rft.atitle=Section+30%3A+Some+characteristics+related+to+the+incidence+of+cardiovascular+disease+and+death%3A+18+year+follow-up&amp;rft.btitle=The+Framingham+Study%3B+DHEW+Publication+No.+%28NIH%29+74-599&amp;rft.place=Bethesda%2C+MD&amp;rft.pub=National+Heart+and+Lung+Institute&amp;rft.date=1974&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Dustan-20\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Dustan_20-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Dustan_20-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Dustan_20-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Dustan_20-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Dustan_20-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Dustan_20-5\"><sup><i><b>f</b></i></sup></a> <a href=\"#cite_ref-Dustan_20-6\"><sup><i><b>g</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Dustan HP, Roccella EJ, Garrison HH (September 1996). \"Controlling hypertension. A research success story\". <i>Archives of Internal Medicine</i>. <b>156</b> (17): 1926\u201335. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/archinte.156.17.1926\">10.1001/archinte.156.17.1926</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8823146\">8823146</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Controlling+hypertension.+A+research+success+story&amp;rft.volume=156&amp;rft.issue=17&amp;rft.pages=1926-35&amp;rft.date=1996-09&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.156.17.1926&amp;rft_id=info%3Apmid%2F8823146&amp;rft.aulast=Dustan&amp;rft.aufirst=HP&amp;rft.au=Roccella%2C+EJ&amp;rft.au=Garrison%2C+HH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-21\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-21\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ayman D (1930-07-26). \"An evaluation of therapeutic results in essential hypertension: i. the interpretation of symptomatic relief\". <i>Journal of the American Medical Association</i>. <b>95</b> (4): 246\u2013249. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.1930.02720040004002\">10.1001/jama.1930.02720040004002</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=An+evaluation+of+therapeutic+results+in+essential+hypertension%3A+i.+the+interpretation+of+symptomatic+relief&amp;rft.volume=95&amp;rft.issue=4&amp;rft.pages=246-249&amp;rft.date=1930-07-26&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1930.02720040004002&amp;rft.aulast=Ayman&amp;rft.aufirst=David&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Evans_199\u2013228-22\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Evans_199\u2013228_22-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Evans_199\u2013228_22-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Evans W, Loughnan O (July 1939). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC503854\">\"The drug treatment of hyperpiesia\"</a>. <i>British Heart Journal</i>. <b>1</b> (3): 199\u2013228. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1136/hrt.1.3.199\">10.1136/hrt.1.3.199</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC503854\">503854</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18609819\">18609819</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Heart+Journal&amp;rft.atitle=The+drug+treatment+of+hyperpiesia&amp;rft.volume=1&amp;rft.issue=3&amp;rft.pages=199-228&amp;rft.date=1939-07&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC503854&amp;rft_id=info%3Apmid%2F18609819&amp;rft_id=info%3Adoi%2F10.1136%2Fhrt.1.3.199&amp;rft.aulast=Evans&amp;rft.aufirst=W&amp;rft.au=Loughnan%2C+O&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC503854&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:1-23\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:1_23-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:1_23-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ayman D (1931-06-20). \"An evaluation of therapeutic results in essential hypertension: II. the interpretation of blood pressure reductions\". <i>Journal of the American Medical Association</i>. <b>96</b> (25): 2091\u20132094. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.1931.02720510011003\">10.1001/jama.1931.02720510011003</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=An+evaluation+of+therapeutic+results+in+essential+hypertension%3A+II.+the+interpretation+of+blood+pressure+reductions&amp;rft.volume=96&amp;rft.issue=25&amp;rft.pages=2091-2094&amp;rft.date=1931-06-20&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1931.02720510011003&amp;rft.aulast=Ayman&amp;rft.aufirst=David&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-24\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-24\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ayman D (1931-05-30). \"Potassium thiocyanate in the treatment of essential hypertension: its impracticability\". <i>Journal of the American Medical Association</i>. <b>96</b> (22): 1852\u20131857. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1001/jama.1931.02720480010004\">10.1001/jama.1931.02720480010004</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=Potassium+thiocyanate+in+the+treatment+of+essential+hypertension%3A+its+impracticability&amp;rft.volume=96&amp;rft.issue=22&amp;rft.pages=1852-1857&amp;rft.date=1931-05-30&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1931.02720480010004&amp;rft.aulast=Ayman&amp;rft.aufirst=David&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:0-25\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:0_25-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:0_25-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Moser M (August 2006). \"Historical perspectives on the management of hypertension\". <i>Journal of Clinical Hypertension</i>. <b>8</b> (8 Suppl 2): 15\u201320; quiz 39. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1524-6175.2006.05836.x\">10.1111/j.1524-6175.2006.05836.x</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16894244\">16894244</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Hypertension&amp;rft.atitle=Historical+perspectives+on+the+management+of+hypertension&amp;rft.volume=8&amp;rft.issue=8+Suppl+2&amp;rft.pages=15-20%3B+quiz+39&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1524-6175.2006.05836.x&amp;rft_id=info%3Apmid%2F16894244&amp;rft.aulast=Moser&amp;rft.aufirst=M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-:2-26\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-:2_26-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-:2_26-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation book\">Laragh JH, Brenner BM (1995). <a rel=\"nofollow\" class=\"external text\" href=\"https://www.worldcat.org/oclc/30894228\"><i>Hypertension&#160;: pathophysiology, diagnosis, and management</i></a> (2nd ed.). New York: Raven Press. <a href=\"/wiki/International_Standard_Book_Number\" title=\"International Standard Book Number\">ISBN</a>&#160;<a href=\"/wiki/Special:BookSources/9780781701570\" title=\"Special:BookSources/9780781701570\">9780781701570</a>. <a href=\"/wiki/OCLC\" title=\"OCLC\">OCLC</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.worldcat.org/oclc/30894228\">30894228</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Hypertension+%3A+pathophysiology%2C+diagnosis%2C+and+management&amp;rft.place=New+York&amp;rft.edition=2nd&amp;rft.pub=Raven+Press&amp;rft.date=1995&amp;rft_id=info%3Aoclcnum%2F30894228&amp;rft.isbn=9780781701570&amp;rft.aulast=Laragh&amp;rft.aufirst=John+H&amp;rft.au=Brenner%2C+Barry+M&amp;rft_id=https%3A%2F%2Fwww.worldcat.org%2Foclc%2F30894228&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-27\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-27\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wien R, Mason DF (December 1951). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1509152\">\"Some actions of hexamethonium and certain homologues\"</a>. <i>British Journal of Pharmacology and Chemotherapy</i>. <b>6</b> (4): 611\u201329. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1111/j.1476-5381.1951.tb00672.x\">10.1111/j.1476-5381.1951.tb00672.x</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1509152\">1509152</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14904886\">14904886</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Journal+of+Pharmacology+and+Chemotherapy&amp;rft.atitle=Some+actions+of+hexamethonium+and+certain+homologues&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=611-29&amp;rft.date=1951-12&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1509152&amp;rft_id=info%3Apmid%2F14904886&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1476-5381.1951.tb00672.x&amp;rft.aulast=Wien&amp;rft.aufirst=R&amp;rft.au=Mason%2C+DF&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1509152&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-28\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-28\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Johnson RP (October 1953). \"The treatment of hypertension with 1-hydrazinophthalazine (apresoline)\". <i>American Heart Journal</i>. <b>46</b> (4): 592\u2013601. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/0002-8703%2853%2990069-6\">10.1016/0002-8703(53)90069-6</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/13092045\">13092045</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=American+Heart+Journal&amp;rft.atitle=The+treatment+of+hypertension+with+1-hydrazinophthalazine+%28apresoline%29&amp;rft.volume=46&amp;rft.issue=4&amp;rft.pages=592-601&amp;rft.date=1953-10&amp;rft_id=info%3Adoi%2F10.1016%2F0002-8703%2853%2990069-6&amp;rft_id=info%3Apmid%2F13092045&amp;rft.aulast=Johnson&amp;rft.aufirst=RP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-29\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-29\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Vakil RJ (August 1955). \"Rauwolfia serpentina in the treatment of high blood pressure; a review of the literature\". <i>Circulation</i>. <b>12</b> (2): 220\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/01.cir.12.2.220\">10.1161/01.cir.12.2.220</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/13240803\">13240803</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=Rauwolfia+serpentina+in+the+treatment+of+high+blood+pressure%3B+a+review+of+the+literature&amp;rft.volume=12&amp;rft.issue=2&amp;rft.pages=220-9&amp;rft.date=1955-08&amp;rft_id=info%3Adoi%2F10.1161%2F01.cir.12.2.220&amp;rft_id=info%3Apmid%2F13240803&amp;rft.aulast=Vakil&amp;rft.aufirst=RJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-30\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-30\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Greene JA (2005). \"Releasing the flood waters: diuril and the reshaping of hypertension\". <i>Bulletin of the History of Medicine</i>. <b>79</b> (4): 749\u201394. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1353/bhm.2005.0153\">10.1353/bhm.2005.0153</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16327086\">16327086</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Bulletin+of+the+History+of+Medicine&amp;rft.atitle=Releasing+the+flood+waters%3A+diuril+and+the+reshaping+of+hypertension&amp;rft.volume=79&amp;rft.issue=4&amp;rft.pages=749-94&amp;rft.date=2005&amp;rft_id=info%3Adoi%2F10.1353%2Fbhm.2005.0153&amp;rft_id=info%3Apmid%2F16327086&amp;rft.aulast=Greene&amp;rft.aufirst=JA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-31\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-31\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Novello FC, Sprague JM (1957). \"Benzothiadiazine dioxides as novel diuretics\". <i>J. Am. Chem. Soc</i>. <b>79</b> (8): 2028\u20132029. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/ja01565a079\">10.1021/ja01565a079</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Am.+Chem.+Soc.&amp;rft.atitle=Benzothiadiazine+dioxides+as+novel+diuretics&amp;rft.volume=79&amp;rft.issue=8&amp;rft.pages=2028-2029&amp;rft.date=1957&amp;rft_id=info%3Adoi%2F10.1021%2Fja01565a079&amp;rft.aulast=Novello&amp;rft.aufirst=FC&amp;rft.au=Sprague%2C+JM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-32\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-32\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Freis ED (1974). \"The Veterans Administration cooperative study on antihypertensive agents. Implications for stroke prevention\". <i>Stroke</i>. <b>5</b> (1): 76\u20137. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1161/01.STR.5.1.76\">10.1161/01.STR.5.1.76</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/4811316\">4811316</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Stroke&amp;rft.atitle=The+Veterans+Administration+cooperative+study+on+antihypertensive+agents.+Implications+for+stroke+prevention&amp;rft.volume=5&amp;rft.issue=1&amp;rft.pages=76-7&amp;rft.date=1974&amp;rft_id=info%3Adoi%2F10.1161%2F01.STR.5.1.76&amp;rft_id=info%3Apmid%2F4811316&amp;rft.aulast=Freis&amp;rft.aufirst=ED&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-33\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-33\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Black JW, Crowther AF, Shanks RG, Smith LH, Dornhorst AC (May 1964). \"A new adrenergic betareceptor antagonist\". <i>Lancet</i>. <b>1</b> (7342): 1080\u20131. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/S0140-6736%2864%2991275-9\">10.1016/S0140-6736(64)91275-9</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/14132613\">14132613</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Lancet&amp;rft.atitle=A+new+adrenergic+betareceptor+antagonist&amp;rft.volume=1&amp;rft.issue=7342&amp;rft.pages=1080-1&amp;rft.date=1964-05&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2864%2991275-9&amp;rft_id=info%3Apmid%2F14132613&amp;rft.aulast=Black&amp;rft.aufirst=JW&amp;rft.au=Crowther%2C+AF&amp;rft.au=Shanks%2C+RG&amp;rft.au=Smith%2C+LH&amp;rft.au=Dornhorst%2C+AC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-34\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-34\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Ondetti MA, Rubin B, Cushman DW (April 1977). \"Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents\". <i>Science</i>. <b>196</b> (4288): 441\u20134. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1126/science.191908\">10.1126/science.191908</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/191908\">191908</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Science&amp;rft.atitle=Design+of+specific+inhibitors+of+angiotensin-converting+enzyme%3A+new+class+of+orally+active+antihypertensive+agents&amp;rft.volume=196&amp;rft.issue=4288&amp;rft.pages=441-4&amp;rft.date=1977-04&amp;rft_id=info%3Adoi%2F10.1126%2Fscience.191908&amp;rft_id=info%3Apmid%2F191908&amp;rft.aulast=Ondetti&amp;rft.aufirst=MA&amp;rft.au=Rubin%2C+B&amp;rft.au=Cushman%2C+DW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-35\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-35\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Wexler RR, Greenlee WJ, Irvin JD, Goldberg MR, Prendergast K, Smith RD, Timmermans PB (February 1996). \"Nonpeptide angiotensin II receptor antagonists: the next generation in antihypertensive therapy\". <i>Journal of Medicinal Chemistry</i>. <b>39</b> (3): 625\u201356. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1021/jm9504722\">10.1021/jm9504722</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/8576904\">8576904</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Medicinal+Chemistry&amp;rft.atitle=Nonpeptide+angiotensin+II+receptor+antagonists%3A+the+next+generation+in+antihypertensive+therapy&amp;rft.volume=39&amp;rft.issue=3&amp;rft.pages=625-56&amp;rft.date=1996-02&amp;rft_id=info%3Adoi%2F10.1021%2Fjm9504722&amp;rft_id=info%3Apmid%2F8576904&amp;rft.aulast=Wexler&amp;rft.aufirst=RR&amp;rft.au=Greenlee%2C+WJ&amp;rft.au=Irvin%2C+JD&amp;rft.au=Goldberg%2C+MR&amp;rft.au=Prendergast%2C+K&amp;rft.au=Smith%2C+RD&amp;rft.au=Timmermans%2C+PB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-36\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-36\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Jensen C, Herold P, Brunner HR (May 2008). \"Aliskiren: the first renin inhibitor for clinical treatment\". <i>Nature Reviews. Drug Discovery</i>. <b>7</b> (5): 399\u2013410. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1038/nrd2550\">10.1038/nrd2550</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/18340340\">18340340</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Drug+Discovery&amp;rft.atitle=Aliskiren%3A+the+first+renin+inhibitor+for+clinical+treatment&amp;rft.volume=7&amp;rft.issue=5&amp;rft.pages=399-410&amp;rft.date=2008-05&amp;rft_id=info%3Adoi%2F10.1038%2Fnrd2550&amp;rft_id=info%3Apmid%2F18340340&amp;rft.aulast=Jensen&amp;rft.aufirst=C&amp;rft.au=Herold%2C+P&amp;rft.au=Brunner%2C+HR&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHistory+of+hypertension\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div></div>\n\n<!-- \nNewPP limit report\nParsed by mw1243\nCached time: 20180903174711\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.356 seconds\nReal time usage: 0.379 seconds\nPreprocessor visited node count: 1574/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 65275/2097152 bytes\nTemplate argument size: 87/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 50963/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.198/10.000 seconds\nLua memory usage: 3.13 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  288.229      1 Template:Reflist\n100.00%  288.229      1 -total\n 66.13%  190.609     26 Template:Cite_journal\n 14.57%   41.989     10 Template:Cite_book\n  0.72%    2.065      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:35958818-0!canonical and timestamp 20180903174711 and revision id 854609072\n -->\n</div>"},"langlinks":[{"lang":"es","url":"https://es.wikipedia.org/wiki/Historia_de_la_hipertensi%C3%B3n","langname":"Spanish","autonym":"espa\u00f1ol","*":"Historia de la hipertensi\u00f3n"}],"categories":[{"sortkey":"","*":"Hypertension"},{"sortkey":"Hypertension","*":"History_of_medicine"}],"links":[{"ns":0,"exists":"","*":"Angina pectoris"},{"ns":0,"exists":"","*":"Angiotensin converting enzyme"},{"ns":0,"exists":"","*":"Angiotensin receptor blockers"},{"ns":0,"exists":"","*":"Aulus Cornelius Celsus"},{"ns":0,"exists":"","*":"Barbiturate"},{"ns":0,"exists":"","*":"Beta blocker"},{"ns":0,"exists":"","*":"Bismuth"},{"ns":0,"exists":"","*":"Blood letting"},{"ns":0,"exists":"","*":"Blood pressure"},{"ns":0,"exists":"","*":"Bright's disease"},{"ns":0,"exists":"","*":"Bromide"},{"ns":0,"exists":"","*":"Calcium channel blockers"},{"ns":0,"exists":"","*":"Captopril"},{"ns":0,"exists":"","*":"Chlorothiazide"},{"ns":0,"exists":"","*":"Clifford Allbutt"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Diuretics"},{"ns":0,"exists":"","*":"Drug design"},{"ns":0,"exists":"","*":"Essential hypertension"},{"ns":0,"exists":"","*":"Framingham Heart Study"},{"ns":0,"exists":"","*":"Franklin D. Roosevelt"},{"ns":0,"exists":"","*":"Frederick Akbar Mahomed"},{"ns":0,"exists":"","*":"Galen"},{"ns":0,"exists":"","*":"Heart failure"},{"ns":0,"exists":"","*":"Hexamethonium"},{"ns":0,"exists":"","*":"Hippocrates"},{"ns":0,"exists":"","*":"Hydralazine"},{"ns":0,"exists":"","*":"Hydrochlorothiazide"},{"ns":0,"exists":"","*":"International Standard Book Number"},{"ns":0,"exists":"","*":"James W. Black"},{"ns":0,"exists":"","*":"Kidney failure"},{"ns":0,"exists":"","*":"Korotkoff sounds"},{"ns":0,"exists":"","*":"Lasker-DeBakey Clinical Medical Research Award"},{"ns":0,"exists":"","*":"Lasker Award"},{"ns":0,"exists":"","*":"Leech"},{"ns":0,"exists":"","*":"Liverpool University"},{"ns":0,"exists":"","*":"Malignant hypertension"},{"ns":0,"exists":"","*":"Mayo Clinic"},{"ns":0,"exists":"","*":"National Institutes of Health"},{"ns":0,"exists":"","*":"Nikolai Korotkoff"},{"ns":0,"exists":"","*":"Nobel Prize in Physiology or Medicine"},{"ns":0,"exists":"","*":"OCLC"},{"ns":0,"exists":"","*":"Papaverine"},{"ns":0,"exists":"","*":"Paul Dudley White"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Randomized controlled trial"},{"ns":0,"exists":"","*":"Rauwolfia serpentina"},{"ns":0,"exists":"","*":"Renin inhibitors"},{"ns":0,"exists":"","*":"Renin\u2013angiotensin system"},{"ns":0,"exists":"","*":"Reserpine"},{"ns":0,"exists":"","*":"Rice diet"},{"ns":0,"exists":"","*":"Richard Bright (physician)"},{"ns":0,"exists":"","*":"Scipione Riva-Rocci"},{"ns":0,"exists":"","*":"Sodium thiocyanate"},{"ns":0,"exists":"","*":"Sphygmograph"},{"ns":0,"exists":"","*":"Sphygmomanometer"},{"ns":0,"exists":"","*":"Stephen Hales"},{"ns":0,"exists":"","*":"Stroke"},{"ns":0,"exists":"","*":"Sulfanilamide"},{"ns":0,"exists":"","*":"Sympathectomy"},{"ns":0,"exists":"","*":"Sympathetic nervous system"},{"ns":0,"exists":"","*":"Tetramethylammonium chloride"},{"ns":0,"exists":"","*":"Thomas Young (scientist)"},{"ns":0,"exists":"","*":"United States Department of Veterans Affairs"},{"ns":0,"exists":"","*":"Verapamil"},{"ns":0,"exists":"","*":"William Harvey"},{"ns":0,"exists":"","*":"World War II"},{"ns":0,"exists":"","*":"Yellow Emperor"}],"templates":[{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Cite book"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC1295564","//www.ncbi.nlm.nih.gov/pubmed/1744849","//doi.org/10.1161/HYPERTENSIONAHA.111.177766","//www.ncbi.nlm.nih.gov/pubmed/21859967","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2104234","//www.ncbi.nlm.nih.gov/pubmed/20895925","//doi.org/10.1046/j.1523-1755.2000.00895.x","//www.ncbi.nlm.nih.gov/pubmed/10652052","//doi.org/10.1038/ki.1996.209","//www.ncbi.nlm.nih.gov/pubmed/8731118","https://archive.org/details/hyperpiesiahyper00shaw","https://www.worldcat.org/oclc/30894228","//www.worldcat.org/oclc/30894228","https://books.google.com/books?id=Q-HIVbL4OxAC&pg=PA4","//doi.org/10.1001/archinte.1928.00130140003001","//doi.org/10.7326/0003-4819-72-4-579","//www.ncbi.nlm.nih.gov/pubmed/4908628","//www.ncbi.nlm.nih.gov/pmc/articles/PMC2314188","//doi.org/10.1136/bmj.2.3679.43","//www.ncbi.nlm.nih.gov/pubmed/20776269","//doi.org/10.1111/j.1524-6175.2006.05836.x","//www.ncbi.nlm.nih.gov/pubmed/16894244","//www.ncbi.nlm.nih.gov/pubmed/12987687","//doi.org/10.1001/archinte.156.17.1926","//www.ncbi.nlm.nih.gov/pubmed/8823146","//doi.org/10.1001/jama.1930.02720040004002","//www.ncbi.nlm.nih.gov/pmc/articles/PMC503854","//doi.org/10.1136/hrt.1.3.199","//www.ncbi.nlm.nih.gov/pubmed/18609819","//doi.org/10.1001/jama.1931.02720510011003","//doi.org/10.1001/jama.1931.02720480010004","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1509152","//doi.org/10.1111/j.1476-5381.1951.tb00672.x","//www.ncbi.nlm.nih.gov/pubmed/14904886","//doi.org/10.1016/0002-8703(53)90069-6","//www.ncbi.nlm.nih.gov/pubmed/13092045","//doi.org/10.1161/01.cir.12.2.220","//www.ncbi.nlm.nih.gov/pubmed/13240803","//doi.org/10.1353/bhm.2005.0153","//www.ncbi.nlm.nih.gov/pubmed/16327086","//doi.org/10.1021/ja01565a079","//doi.org/10.1161/01.STR.5.1.76","//www.ncbi.nlm.nih.gov/pubmed/4811316","//doi.org/10.1016/S0140-6736(64)91275-9","//www.ncbi.nlm.nih.gov/pubmed/14132613","//doi.org/10.1126/science.191908","//www.ncbi.nlm.nih.gov/pubmed/191908","//doi.org/10.1021/jm9504722","//www.ncbi.nlm.nih.gov/pubmed/8576904","//doi.org/10.1038/nrd2550","//www.ncbi.nlm.nih.gov/pubmed/18340340"],"sections":[{"toclevel":1,"level":"2","line":"Treatment and Medications","number":"1","index":"1","fromtitle":"History_of_hypertension","byteoffset":9641,"anchor":"Treatment_and_Medications"},{"toclevel":1,"level":"2","line":"References","number":"2","index":"2","fromtitle":"History_of_hypertension","byteoffset":18961,"anchor":"References"}],"parsewarnings":[],"displaytitle":"History of hypertension","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q7390943"}]}}